A prospective randomized trial of arginine vasopressin in the treatment of vasodilatory shock after left ventricular assist device placement

Circulation

Volumn 96, Issue 9 SUPPL., 1997, Pages

  Argenziano, Michael ^a   Choudhri, Asim F ^a   Oz, Mehmet C ^a,b   Rose, Eric A ^a   Smith, Craig R ^a   Landry, Donald W ^a,b  

^a College of Physicians and Surgeons ^*  (United States)

^b Milstein Hospital   (United States)

Author keywords

Cardiopulmonary bypass; Shock; Vasodilatation; Vasopressin; Ventricular assistance

Indexed keywords

ARGIPRESSIN; NORADRENALIN;

ADULT; ARTICLE; ASSISTED CIRCULATION; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; HYPOTENSION; INTRAVENOUS DRUG ADMINISTRATION; MALE; MEAN ARTERIAL PRESSURE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SHOCK; VASCULAR RESISTANCE; VASODILATATION; VASOPRESSIN BLOOD LEVEL;

ARGININE VASOPRESSIN; CARDIOPULMONARY BYPASS; FEMALE; HEART-ASSIST DEVICES; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SHOCK; VASODILATION;

EID: 0343144803     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Mills SA. Cerebral injury and cardiac operations. Ann Thorac Surg. 1993;56(suppl 5):S86-S91.
2. Moat NE, Shore DF, Evans TW. Organ dysfunction and cardiopulmonary bypass: the role of complement and complement regulatory proteins. Eur J Cardiothorac Surg. 1993;7:563-573.
3. Meadows D, Edwards JD, Wilkins RG, Nightingale P. Reversal of intractable septic shock with norepinephrine therapy. Crit Care Med. 1988;16:663-666.
4. Winslow EJ, Loeb HS, Rahimtoola SH, et al. Hemodynamic studies and results of therapy in 50 patients with bacteremic shock. Am J Med. 1973;54:421-425.
5. Smuylan H, Cuddy RP, Eich RH. Hemodynamic effects of pressor agents in septic and myocardial infarction shock. JAMA. 1964;190: 188-194.
6. Chernow B, Roth BL. Pharmacologic manipulation of the peripheral vasculature in shock: clinical and experimental approaches. Circ Shock. 1986;18:141-155.
7. Powers FM, Pifarre R, Thomas JX Jr. Ventricular dysfunction in norepinephrine-induced cardiomyopathy. Circ Shock. 1994;43: 122-129.
8. Hayes MA, Yau EH, Hinds CJ, Watson JD. Symmetrical peripheral gangrene: association with noradrenaline administration. Intensive Care Med. 1992;18:433-436.
9. Rump AF, Klaus W. Evidence for norepinephrine cardiotoxicity mediated by superoxide anion radicals in isolated rabbit hearts. Naunyn-Schmiedebergs Arch Pharmacol. 1994;349:295-300.
10. Grollman A, Geiling EMK. The cardiovascular and metabolic reactions of man to the intramuscular injection of posterior pituitary liquid (Pituitrin), Pitressin, and Pitocin. J Pharmacol Exp Therap. 1932;46:447-460.
11. Graybiel A, Glendy RE. Circulatory effects following the intravenous administration of Pitressin in normal persons and in patients with hypertension and angina pectoris. Am Heart J. 1941;21: 481-489.
12. Wagner HN Jr, Braunwald E. The pressor effect of the antidiuretic principle of the posterior pituitary in orthostatic hypotension. J Clin Invest. 1956;35:1412-1418.
13. Aisenbrey GA, Handelman WA, Arnold P, Manning M, Schrier RW. Vascular effects of arginine vasopressin during fluid deprivation in the rat. J Clin Invest. 1981;67:961-968.
14. Schwartz J, Reid IA. Effect of vasopressin blockade on blood pressure regulation during hemorrhage in conscious dogs. Endocrinology. 1981;108:1778-1780.
15. Schwartz J, Keil LC, Maselli J, Reid IA. Role of vasopressin in blood pressure regulation during adrenal insufficiency. Endocrinology. 1983;112:234-238.
16. Landry DW, Levin HR, Gallant EM, Ashton RC Jr, Seo S, D'Alessandro DA, Oz MC, Oliver JA. Vasopressin deficiency in vasodilatory septic shock. Crit Care Med. 1997. In press.
17. Thaker U, Geary V, Chalmers P, Sheikh F. Low systemic vascular resistance during cardiac surgery: case reports, brief review, and management with angiotensin II. J Cardiothorac Anesth. 1990;4: 360-363.
18. Egener TH, Comunale ME, Leckie RS. The use of a somatostatin analog in the treatment of refractory hypotension after cardiopulmonary bypass. J Cardiothorac Vasc Anesth. 1992;6:458-460.
19. Sakurai K. A simple and highly sensitive radioimmunoassay for 8-arginine vasopressin in human plasma using a reversed-phase C18 silica column. Folia Endocrinol. 1985;61:724-736.
20. Philbin DM, Coggins CH. Plasma vasopressin levels during cardiopulmonary bypass with and without profound haemodilution. Can Anaesth Soc. 1978;25:282-285.
21. Philbin DM, Coggins CH. Plasma antidiuretic hormone levels in cardiac surgical patients during morphine and halothane anaesthesia. Anesthesiology. 1978;48:95-98.
22. Wu W-h, Zbuzek VK, Bellevue G. Vasopressin release during cardiac operation. J Thorac Cardiovasc Surg. 1980;79:83-90.
23. Levine FH, Philbin DN, Kono K, et al. Plasma vasopressin levels and urinary sodium excretion during cardiopulmonary bypass with and without pulsatile flow. Ann Thorac Surg. 1981;32:63-67.
24. Feddersen K, Aurell M, Delin K, Haggendal J, Aren C, Radegran K. Effects of cardiopulmonary bypass and prostacyclin on plasma catecholamines, angiotensin II and arginine vasopressin. Acta Anaesthesiol Scand. 1985;29:224-230.
25. Agnoletti G, Scotti C, Panzali AF, Ceconi C, Curello S, Alfieri O, Marzollo P, Bini R, Albertini A, Ferrari A. Plasma levels of atrial natriuretic factor (ANF) and urinary excretion on ANF, arginine vasopressin and catecholamines in children with congenital heart disease: effect of cardiac surgery. Eur J Cardiothorac Surg. 1993;7: 533-539.
26. Mohring J, Glanzer K, Maciel JA Jr, Dusing R, Kramer HJ, Arbogast R, Koch-Weser J. Greatly enhanced pressor response to antidiuretic hormone in patients with impaired cardiovascular reflexes due to idiopathic orthostatic hypotension. J Cardiovasc Pharmacol. 1980;2:367-376.
27. Landry DW, Levin HR, Gallant EM, Ashton RC Jr, Seo S, D'Alessandro D, Oz MC, Oliver JA. Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation. 1997;95: 1122-1125.
28. Kuan P, Messenger JC, Ellestad MH. Transient central diabetes insipidus after aortocoronary bypass operations. Am J Cardiol. 1983;52:1181-1183.
29. Robinson RO, Pagliero KM. Polyuria after cardiac surgery. BMJ. 1970;3:265-266.
30. Moreau R, Hadengue A, Soupisonechin T, Assous M, Roche-Sicot J, Sicot C. Abnormal pressor response to vasopressin in patients with cirrhosis: Evidence for impaired buffering mechanisms. Hepatology. 1990;12:7-12.
31. Zerbe RL, Henry DP, Robertson GL. Vasopressin response to orthostatic hypotension: etiologic and clinical implications. Am J Med. 1983;74:265-271.
32. Zeitlhofer J, Asenbaum S, Spiss C, Wimmer A, Mayr N, Wolner E, Defecke L. Central nervous system function after cardiopulmonary bypass. Eur Heart J. 1993;14:885-890.
33. Murphy DA, Armour JA. Influences of cardiopulmonary bypass, temperature, cardioplegia, and topical hypothermia on cardiac innervation. J Thorac Cardiovasc Surg. 1992;103:1192-1199.
34. Jones CW, Pickering BT. Comparison of the effects of water deprivation and sodium chloride imbibition on the hormone content of the neurohypophysis of the rat. J Physiol. 1969;203: 449-458.
35. Cooke CR, Wall BM, Jones GV, Presley DN, Share L. Reversible vasopressin deficiency in severe hypernatremia. Am J Kidney Dis. 1993;22:44-52.
36. Lindner KH, Brinkmann A, Pfenninger EG, Lurie KG, Goertz A, Lindner IM. Effect of vasopressin on hemodynamic variables, organ blood flow, and acid-base status in a pig model of cardiopulmonary resuscitation. Anesth Analg. 1993;77:427-435.
37. Lindner KH, Prengel AW, Brinkmann A, Strohmenger HU, Lindner IM, Lurie KG. Vasopressin administration in refractory cardiac arrest. Ann Intern Med. 1996;124:1061-1064.